Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha P Mandovra

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|November 26, 2019
[Interventionen beim Asthma COPD]Neha P Mandovra, Jörg D Leuppi, Felix J F Herth, et al.
Respiration; International Review of Thoracic Diseases|January 15, 2020
High Incidence of New-Onset Joint Pain in Patients on Fluoroquinolones as Antituberculous TreatmentNeha P Mandovra, Tejashree T Lele, Preyas J Vaidya, et al.
ERJ Open Research|November 23, 2019
EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathyPrashant N Chhajed, Preyas J Vaidya, Neha P Mandovra, et al.
Journal of Clinical Medicine|October 28, 2023
Factors Affecting Best-Tolerated Dose of Pirfenidone in Patients with Fibrosing Interstitial Lung DiseaseNeha P Mandovra, Preyas J Vaidya, Ria S Shah, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|November 26, 2019
[Interventionen beim Asthma COPD]Neha P Mandovra, Jörg D Leuppi, Felix J F Herth, et al.
Respiration; International Review of Thoracic Diseases|January 15, 2020
High Incidence of New-Onset Joint Pain in Patients on Fluoroquinolones as Antituberculous TreatmentNeha P Mandovra, Tejashree T Lele, Preyas J Vaidya, et al.
ERJ Open Research|November 23, 2019
EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathyPrashant N Chhajed, Preyas J Vaidya, Neha P Mandovra, et al.
Journal of Clinical Medicine|October 28, 2023
Factors Affecting Best-Tolerated Dose of Pirfenidone in Patients with Fibrosing Interstitial Lung DiseaseNeha P Mandovra, Preyas J Vaidya, Ria S Shah, et al.
Pageof 1